Consequences of warfarin suspension after major bleeding in very elderly patients with non valvular atrial fibrillation

被引:8
|
作者
Zoppellaro, Giacomo [1 ]
Granziera, Serena [2 ]
Bertozzo, Giulia [2 ]
Denas, Gentian [1 ]
Marigo, Lucia [3 ]
Petruzzellis, Florinda [3 ]
Jose, Seena Padayattil [1 ]
Rossi, Katia [3 ]
Nante, Giovanni [3 ]
Pengo, Vittorio [1 ]
机构
[1] Univ Padua, Dept Cardiac Thorac & Vasc Sci, Cardiol Clin, Padua, Italy
[2] Osped Classificato Villa Salus Mestre Venice, Rehabil Ward, Padua, Italy
[3] Univ Padua, Dept Med DIMED, Geriatr Clin, Padua, Italy
关键词
ANTICOAGULANT-THERAPY; STROKE; HEMORRHAGE; RISK; GUIDELINES; AGE; POPULATION; DABIGATRAN; ASPIRIN; COHORT;
D O I
10.1160/TH16-11-0846
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1828 / 1830
页数:3
相关论文
共 50 条
  • [1] Consequences of warfarin suspension after major bleeding in a cohort of very elderly atrial fibrillation patients
    Zoppellaro, G.
    Bertozzo, G.
    Jose, S. Padayattil
    Granziera, S.
    Denas, G.
    Marigo, L.
    Rossi, K.
    Bracco, A.
    Ninnivaggi, C.
    Petruzzellis, F.
    Nante, G.
    Pengo, V.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 511 - 512
  • [2] Consequences of warfarin suspension after major bleeding in a cohort of very elderly patients
    Zoppellaro, G.
    Jose, Padayattil S.
    Bertozzo, G.
    Denas, G.
    Bracco, A.
    Granziera, S.
    Nante, G.
    Pengo, V
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 : 18 - 18
  • [3] Reasons and consequences of warfarin discontinuation in very elderly patients with non valvular atrial fibrillation. An inception cohort study
    Zoppellaro, G.
    Bertozzo, G.
    Granziera, S.
    Denas, G.
    Marigo, L.
    Jose, S. Padayattil
    Rossi, K.
    Petruzzellis, F.
    Nante, G.
    Pengo, V.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 512 - 512
  • [4] Utilization of warfarin in elderly patients with non-valvular atrial fibrillation.
    Youssef, H
    Pomerantz, SC
    Ciesielski, J
    Cavalieri, TA
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S112 - S112
  • [5] Reasons for and consequences of vitamin K antagonist discontinuation in very elderly patients with non-valvular atrial fibrillation
    Bertozzo, G.
    Zoppellaro, G.
    Granziera, S.
    Marigo, L.
    Rossi, K.
    Petruzzellis, F.
    Perissinotto, E.
    Manzato, E.
    Nante, G.
    Pengo, V.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (11) : 2124 - 2131
  • [6] Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation
    Bahit, M. Cecilia
    Lopes, Renato D.
    Wojdyla, Daniel M.
    Held, Claes
    Hanna, Michael
    Vinereanu, Dragos
    Hylek, Elaine M.
    Verheugt, Freek
    Goto, Shinya
    Alexander, John H.
    Wallentin, Lars
    Granger, Christopher B.
    [J]. HEART, 2017, 103 (08) : 623 - 628
  • [7] Ischemic Stroke and Bleeding Risk in Patients with Non-valvular Atrial Fibrillation Treated with Warfarin
    He, S. B.
    Yu, S. H.
    Meng, R.
    Ru, S. W.
    Gong, Z. J.
    Liu, H. M.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 : S406 - S406
  • [8] Bleeding Risk on Warfarin Among Elderly Patients With Atrial Fibrillation
    Cowan, Andrew
    Hylek, Elaine M.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (09) : 932 - 932
  • [9] Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin
    Hylek, Elaine M.
    Held, Claes
    Alexander, John H.
    Lopes, Renato D.
    De Caterina, Raffaele
    Wojdyla, Daniel M.
    Huber, Kurt
    Jansky, Petr
    Steg, Philippe Gabriel
    Hanna, Michael
    Thomas, Laine
    Wallentin, Lars
    Granger, Christopher B.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (20) : 2141 - 2147
  • [10] Warfarin in non-valvular atrial fibrillation
    Dalby, A. J.
    Wessels, P.
    Opie, L. H.
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2013, 103 (12): : 901 - 904